Prelude Therapeutics Incorporated (PRLD) NASDAQ
3.50
-0.32(-8.38%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
3.50
-0.32(-8.38%)
Currency In USD
| Market Cap | 161.86M |
| Enterprise Value | 144.4M |
| P/E Ratio | -3.71 |
| PEG Ratio | -0.08 |
| Price/Sales Ratio | 8.64 |
| Price/Book Ratio | 4.8 |
| Enterprise/Revenue | 8.4 |
| Enterprise/EBITDA | -1.7 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -4.65 |
| Operating Margin | -5.03 |
| Return On Assets | -0.65 |
| Return On Equity | -1.18 |
| Revenue | 12.14M |
| Revenue/Share | 0.2 |
| Gross Profit | 10.43M |
| EBITDA | -102.86M |
| Net Income | -99.5M |
| Diluted EPS | -1.29 |
| Total Cash | 81.55M |
| Total Cash/Share | 0.99 |
| Total Debt | 17.72M |
| Total Debt/Equity | 0.29 |
| Current Ratio | 2.03 |
| Book Value Per Share | 0.73 |
| 52-Week Change | 285.85 |
| 52-Week High | 5.54 |
| 52-Week Low | 0.75 |
| Moving Average 50 Days | 4.22 |
| Moving Average 200 Days | 2.46 |
| Average Volume | 376,373 |
| Shares Outstanding | 78.5M |
| % Held by Institutions | 39.99 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |